News
The investigational MRI contrast agent, gadoquatrane, is designed to deliver effective imaging at a significantly reduced ...
Over a year ago, a new camera stunned the world with its ability to snap 10 trillion frames per second. That speed made it ...
Berlin: Bayer has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational contrast agent gadoquatrane for ...
Bayer seeks US FDA approval for contrast agent, gadoquatrane for contrast-enhanced MRI of the CNS and other body regions: Berlin Wednesday, June 18, 2025, 09:00 Hrs [IST] Bayer an ...
The Global Digital Holographic Microscopy Market is expected to reach at a CAGR of 20.4% during the forecast period 2025-2033. The Digital Holographic Microscopy Market is expanding due to rising ...
13d
Zacks.com on MSNBayer Seeks FDA Approval for MRI Contrast Agent GadoquatraneBayer BAYRY announced that it has submitted a new drug application (“NDA”) to the FDA seeking approval for its ...
The company's application included a submitted dose of 0.04 millimole gadolinium per kilogram of body weight. If approved, gadoquatrane would become the lowest dose macrocyclic gadolinium-based ...
Discover how DXOMARK’s new smartphone camera protocol v6 elevates HDR, portrait, and zoom testing to deliver scores that ...
The developed all-optical signal processing chips pave the way for ultra-low loss, high-speed, high-efficient, high-density ...
LONDON, GREATER LONDON, UNITED KINGDOM, June 20, 2025 /EINPresswire.com/ -- Crucial to the advancement of medical and scientific research, micro-computed tomography has paved the way to some of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results